Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by DIYGuyon Sep 15, 2017 12:10pm

108 Views

Post# 26701447

PP

With any luck the PP closes today and it is the last day we see the price under $1.16. Will the market see the injection of cash as a positive or will it get punished on the dilution. Hoping it is the former not the latter. Would love to see the warrants forced to exercise within 6 months of the price hits the target. Still think it is going to take positive news to move this, like a quick HNSCC trial with without the delays like before

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market